CytomX Therapeutics Announces Third Quarter 2018 Financial Results
Go back to CytomX Therapeutics Announces Third Quarter 2018 Financial Results| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.67 | 52 Week High | $24.68 | |||
| Open | $3.67 | 52 Week Low | $9.10 | |||
| Day High | $3.67 | P/E | N/A | |||
| Day Low | $3.67 | EPS | $0.00 | |||
| Volume | 2,012 | |||||

